OSCR

LTF promotes central nervous system leukemia progression via neutrophil serine proteases.

Code ↔ Paper

The paper beside its authors' code: matches between them have not been computed for this paper yet.

Paper

Loaded from Europe PMC by your browser; OSCR does not store it: doi.org · Europe PMC

The paper is loaded when this pane is shown.

The authors' code

R · 40 lines · 1.1 KB · no license

  1. # if (!requireNamespace("BiocManager", quietly = TRUE)) install.packages("BiocManager")
  2. # BiocManager::install(c("clusterProfiler", "org.Hs.eg.db", "AnnotationDbi", "GO.db"))
  3. # Gene symbols associated with GO terms were retrieved using AnnotationDbi v1.64.1, clusterProfiler v4.10.0, org.Hs.eg.db v3.18.0, and GO.db v3.18.0. GO annotations were based on GOALL mappings.
  4. library(clusterProfiler)
  5. library(org.Hs.eg.db)
  6. library(AnnotationDbi)
  7. library(GO.db)
  8. get_go_gene_symbols <- function(go_ids,
  9. OrgDb = org.Hs.eg.db,
  10. keytype = "GOALL") {
  11. valid_go <- keys(GO.db, keytype = "GOID")
  12. invalid_go <- setdiff(go_ids, valid_go)
  13. if (length(invalid_go) > 0) {
  14. warning("The following GO IDs were not found in GO.db:",
  15. paste(invalid_go, collapse = ", "))
  16. }
  17. go_ids <- intersect(go_ids, valid_go)
  18. if (length(go_ids) == 0) {
  19. return(data.frame())
  20. }
  21. gene_df <- AnnotationDbi::select(
  22. OrgDb,
  23. keys = go_ids,
  24. keytype = keytype,
  25. columns = c("SYMBOL", "ENTREZID", "GOALL", "ONTOLOGYALL")
  26. )
  27. return(gene_df)
  28. }
  29. result <- get_go_gene_symbols("GO:0001817")

GO_Gene_Search.R at commit 04b1472, no license · at the source

Overview

Authors: Yiran Zhang1,2, Huasong Yu1,2, Zhongxiang Jiao1,2, Ming Yang1,2, Wenshan Zhang1,2, Chaoqun Wang1,2,3, Hexiao Zhang1,2, Wei Wang1,2, Minghe Zhang1,2, Xiaoyue Li1,2, Lin Song1,2, Bo Jiang1,2, Junyuan Qi1,2, Yinghui Li1,2, Yingdai Gao1,2
  1. State Key Laboratory of Experimental Hematology, National Clinical Research Center for Blood Diseases, Haihe Laboratory of Cell Ecosystem, Institute of Hematology and Blood Diseases Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Tianjin, China
  2. Tianjin Institutes of Health Science, Tianjin, China
  3. Department of Pharmacy, Children’s Hospital of Soochow University, Suzhou, Jiangsu, China
Journal: Frontiers in pharmacology, volume 17, article 1813396
Dates: received 18 February 2026; accepted 24 April 2026; published online 1 July 2026
Type: Research article · Language: English
License: CC BY
Identifiers: DOI 10.3389/fphar.2026.1813396 · PMID 42460014 · PMCID PMC13368923 · OpenAlex W7166889068
Open access: gold, a free copy (OpenAlex)
Status: code verified (how the code is found and verified)
Categories: mouse (organism)
Methods: Connectivity, Statistics, Smoothing, state filtering, decompositions, Machine learning, Evoked potentials
Keywords: acute myeloid leukemia, central nervous system leukemia, lactoferrin, neutrophil serine proteases, brensocatib
Topic: Acute Myeloid Leukemia Research (Hematology, Medicine), according to OpenAlex
Citations: not cited yet (Europe PMC); 47 references in the paper

Abstract

Introduction: Central nervous system (CNS) infiltration is a severe complication of acute myeloid leukemia (AML), often leading to relapse and poor prognosis. The underlying mechanisms remain poorly understood, limiting the development of effective targeted therapies. Conventional chemotherapy agents capable of crossing the blood-brain barrier (BBB) carry significant toxicity and fail to eliminate leukemia stem cells.

Methods: Using multiple clinical cohorts, we established prognostic prediction model for AML. Using knockdown and overexpression experiments in a mouse leukemia CNS infiltration model, the role of risk factor gene in CNS infiltration was evaluated, along with the attenuating effect of its downstream proteins drug inhibition on leukemia CNS infiltration.

Results: We identify Lactoferrin (LTF) as a risk factor associated with poor AML prognosis using a machine learning–based prognostic model. Through LTF knockdown and overexpression in a mouse leukemia model, we demonstrate its pivotal role in CNS invasion. Mechanistically, neutrophil serine proteases (NSPs) act as downstream effectors of LTF, and pharmacological inhibition with Brensocatib effectively blocks AML cell entry into the brain.

Discussion: Our findings establish LTF as a mediator of CNS infiltration in AML and highlight NSP inhibition as a promising therapeutic strategy.

Reproduced under the paper's license (CC BY), from the paper cited above.

Repository

Its files are read in the Code ↔ Paper reader above.

HuasongYu/GO_Gene_Search

License: none: the authors keep all their rights
State: the link answers, verified on 27 September 2026
Evidence: files inventoried
Commit: 04b1472336011128baba16c42ac63c2d253d6864, 22 April 2026
Languages: R (1)
Size: 2 files, 1 script
Software Heritage: not archived
Found in: the text, “RNA-seq data processing”
Holds: README
Not found: license file, CITATION.cff, environment file, tests, continuous integration, documentation
Tools: clusterProfiler (1 file)
Availability: 1 check, the latest on 27 September 2026: the link answers
  • 27 September 2026: the link answers
2 files

The paper's code and data availability statement is in the Data section.

Tracing map

Proposed by the machine: these links were found in the paper and verified at the source, without human review. The map will receive a Zenodo DOI once one of the paper's authors has validated it with their ORCID.

What the map holds:

  • 1 repository of the authors' code, each at its verified commit, with its license and how the link was found in the paper;
  • 1 script, each with its path and the digest of its content;
  • no match between paragraphs and code yet;
  • neither the text of the paper nor the code itself.

Its JSON (tracing-map.json) is deposited on Zenodo with its DOI once the map is validated.

Data

Datasets cited

Other data links

Data availability statement

The datasets presented in this study can be found in GitHub (https://github.com/HuasongYu/MachineLearn).

Reproduced under the paper's license (CC BY), from the paper cited above.

Versions

The history of this record: each version stored by the harvester or made by a correction of its authors or of the maintainers of its code, and what changed in its facts. The texts of the paper (its abstract, its availability statements) are not part of it; versions that changed only those are not listed.

Version 2, 28 September 2026

  • Funding: added National Natural Science Foundation of China: 82370120; Tianjin Science and Technology Committee

Version 1, 27 September 2026: the first record

Recorded: type, language, journal, volume, pages, dates, 15 authors, 5 keywords, 46 references.

Cite

This paper

Zhang, Y., Yu, H., Jiao, Z., Yang, M., Zhang, W., Wang, C., Zhang, H., Wang, W., Zhang, M., Li, X., Song, L., Jiang, B., Qi, J., Li, Y., & Gao, Y. (2026). LTF promotes central nervous system leukemia progression via neutrophil serine proteases. Frontiers in pharmacology, 17, 1813396. https://doi.org/10.3389/fphar.2026.1813396

BibTeX

@article{zhang2026ltf,
author = {Zhang, Yiran and Yu, Huasong and Jiao, Zhongxiang and Yang, Ming and Zhang, Wenshan and Wang, Chaoqun and Zhang, Hexiao and Wang, Wei and Zhang, Minghe and Li, Xiaoyue and Song, Lin and Jiang, Bo and Qi, Junyuan and Li, Yinghui and Gao, Yingdai},
title = {{LTF promotes central nervous system leukemia progression via neutrophil serine proteases}},
journal = {Frontiers in pharmacology},
year = {2026},
month = jul,
volume = {17},
pages = {1813396},
publisher = {Frontiers Media SA},
issn = {1663-9812},
doi = {10.3389/fphar.2026.1813396},
url = {https://doi.org/10.3389/fphar.2026.1813396},
pmid = {42460014},
pmcid = {PMC13368923}
}

RIS

TY - JOUR
AU - Zhang, Yiran
AU - Yu, Huasong
AU - Jiao, Zhongxiang
AU - Yang, Ming
AU - Zhang, Wenshan
AU - Wang, Chaoqun
AU - Zhang, Hexiao
AU - Wang, Wei
AU - Zhang, Minghe
AU - Li, Xiaoyue
AU - Song, Lin
AU - Jiang, Bo
AU - Qi, Junyuan
AU - Li, Yinghui
AU - Gao, Yingdai
TI - LTF promotes central nervous system leukemia progression via neutrophil serine proteases
T2 - Frontiers in pharmacology
J2 - Front Pharmacol
PY - 2026
DA - 2026/07/01
VL - 17
SP - 1813396
SN - 1663-9812
PB - Frontiers Media SA
DO - 10.3389/fphar.2026.1813396
UR - https://doi.org/10.3389/fphar.2026.1813396
LA - en
ER -

CSL-JSON

{
"id": "10.3389/fphar.2026.1813396",
"type": "article-journal",
"title": "LTF promotes central nervous system leukemia progression via neutrophil serine proteases",
"container-title": "Frontiers in pharmacology",
"author": [
{
"family": "Zhang",
"given": "Yiran"
},
{
"family": "Yu",
"given": "Huasong"
},
{
"family": "Jiao",
"given": "Zhongxiang"
},
{
"family": "Yang",
"given": "Ming"
},
{
"family": "Zhang",
"given": "Wenshan"
},
{
"family": "Wang",
"given": "Chaoqun"
},
{
"family": "Zhang",
"given": "Hexiao"
},
{
"family": "Wang",
"given": "Wei"
},
{
"family": "Zhang",
"given": "Minghe"
},
{
"family": "Li",
"given": "Xiaoyue"
},
{
"family": "Song",
"given": "Lin"
},
{
"family": "Jiang",
"given": "Bo"
},
{
"family": "Qi",
"given": "Junyuan"
},
{
"family": "Li",
"given": "Yinghui"
},
{
"family": "Gao",
"given": "Yingdai"
}
],
"container-title-short": "Front Pharmacol",
"volume": "17",
"page": "1813396",
"DOI": "10.3389/fphar.2026.1813396",
"PMID": "42460014",
"PMCID": "PMC13368923",
"ISSN": "1663-9812",
"publisher": "Frontiers Media SA",
"URL": "https://doi.org/10.3389/fphar.2026.1813396",
"language": "en",
"issued": {
"date-parts": [
[
2026,
7,
1
]
]
}
}

The tracing map gets a citation of its own once an author has validated it and it has a DOI.

Similar papers

The papers with a page that share the most with this one: the tools found in their code, their categories, datasets, cited references and authors, the rarest counting most.

[1] doi:10.1038/s41698-024-00721-8 [code]
Molecular mechanisms and diagnostic model of glioma-related epilepsy.
Journal: NPJ precision oncology
In common: clusterProfiler, 2 references
[2] doi:10.3390/genes16050473 [code]
Enhancing Prognostic Signatures in Glioblastoma with Feature Selection and Regularised Cox Regression.
Journal: Genes
In common: clusterProfiler, 1 reference
[3] doi:10.1038/s41698-025-01260-6 [code]
A machine learning-defined cellular senescence signature systematically enhances prognostication and guides immunotherapy strategies for the treatment of gliomas.
Journal: NPJ precision oncology
In common: clusterProfiler, 1 reference
[4] doi:10.3390/biomedicines13051040
Glioblastoma and Blood Microenvironment Predictive Model for Life Expectancy of Patients.
Journal: Biomedicines
In common: 1 reference
[5] doi:10.1186/s12935-026-04370-8
Machine learning-based prognostic model and single-cell transcriptomic integration for identifying brain metastasis-associated malignant subpopulations and potential therapeutic targets in lung adenocarcinoma.
Journal: Cancer cell international
In common: mouse, 1 reference
[6] doi:10.1186/s12874-026-03050-5 [code]
A comprehensive simulation study evaluating the predictive performance of Cox proportional hazards model and machine learning methods for time-to-event data.
Journal: BMC medical research methodology
In common: 1 reference
[7] doi:10.1038/s41598-026-47047-y [code]
Imaging-genetics-based dementia risk prediction using deep survival neural networks in the Rotterdam Study.
Journal: Scientific reports
In common: 1 reference
[8] doi:10.1002/epi.70101 [code]
Development and validation of a deep survival model to predict time to seizure from routine electroencephalography.
Journal: Epilepsia
In common: 1 reference
[9] doi:10.1371/journal.pone.0336476 [code]
A meaningful prediction of functional decline in amyotrophic lateral sclerosis based on multi-event survival analysis.
Journal: PloS one
In common: 1 reference
[10] doi:10.3389/fnins.2025.1627497 [code]
GenCPM: a toolbox for generalized connectome-based predictive modeling.
Journal: Frontiers in neuroscience
In common: 1 reference

Contribute

The authors of this paper can claim it, correct its record and validate its tracing map, and the maintainers of its code (its owner, or a public member of its organization) correct what it says of their repository; anyone signed in can ask for its removal. Every request goes to OSCR's own machine, which answers it; your account page follows them.

Sign in with ORCID to claim this paper as one of its authors, correct its record or validate its tracing map: when the paper's metadata lists your ORCID iD, you are recognized at once. Maintainers of its code: sign in with GitHub, then claim the repository on your account page.

Add the badge to the code's README

OSCR: the badge of this paper

If you are an author or a maintainer of this paper's code, you can add this badge. It says what OSCR knows of the paper (its code, its validated tracing map) and links the code to this page. Paste one of these snippets under the README's title. Keep the two marks around it, so that the badge can be replaced in place and is never added twice. OSCR changes nothing in your repository.

Markdown
<!-- oscr-badge:start -->
[![OSCR](https://openscicode.org/badge/doi/10.3389/fphar.2026.1813396.svg)](https://openscicode.org/badge/doi/10.3389/fphar.2026.1813396)
<!-- oscr-badge:end -->
reStructuredText
.. oscr-badge:start

.. image:: https://openscicode.org/badge/doi/10.3389/fphar.2026.1813396.svg
   :target: https://openscicode.org/badge/doi/10.3389/fphar.2026.1813396
   :alt: OSCR

.. oscr-badge:end
HTML
<!-- oscr-badge:start -->
<a href="https://openscicode.org/badge/doi/10.3389/fphar.2026.1813396"><img src="https://openscicode.org/badge/doi/10.3389/fphar.2026.1813396.svg" alt="OSCR"></a>
<!-- oscr-badge:end -->

On GitHub, open the README, choose Edit (the pencil), paste the snippet under the title, then "Commit changes".

If you choose to, you can have the badge kept up to date for you, with oscr badge --write from the command line or with the GitHub Action in your repository's workflows. Every other form and option (a card, AsciiDoc, LaTeX, shields.io) is on the badge page.

Request its removal

To ask OSCR to remove this record, the copies of its authors' scripts or its tracing map, use the removal request page: signed in, you say who you are, what to remove and why, then review and confirm the request. Published rules decide every request (how).

Discussion, reproductions, activity

Discussion: code errors and mismatches between the code and the paper about this paper and its code, from readers and its authors, beside the paper and its tracing map.

Report a mismatch between the code and the paper · Report a code error (signed in)

Reproductions: reports from readers who ran the authors' code and did not get the paper's result, what they ran, with which environment, commit and data.

Report a reproduction failure (signed in)

Versions of its code: the releases of its code tied to a version of this paper (the preprint, the accepted manuscript, the version of record…), each with the tracing map versioned with it.

Activity: what happens around this paper: new versions of its record, its map's validation, discussions and reproductions. It opens with sign-in.